Eurofins Scientific SE plans to acquire diagnostics testing provider Genoma Group Srl (Genoma).

Based in Luxembourg, Eurofins is a bio-analytical testing and genomic services firm.

The acquisition will enable the company to enter Italy’s clinical testing market and to strengthen its position in Europe’s specialty diagnostic testing market.

Swedish private equity firm EQT AB, through its affiliate EQT VII Fund, plans to procure a 20% stake in German-based Otto Bock HealthCare GmbH.

The acquisition will enable Otto Bock to focus on innovation and future growth.

Johnson and Johnson (J&J) subsidiary DePuy Synthes Products Inc has announced the purchase of Innovative Surgical Solutions LLC (dba Sentio, LLC).

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
"The addition will strengthen DePuy Synthes’ spine portfolio and foster future innovation."

DePuy Synthes is an orthopaedics and neuro products provider, while Sentio is a nerve localisation technology provider for spine surgery.

Both the companies involved in the acquisition are based in the US.

The addition will strengthen DePuy Synthes’ spine portfolio and foster future innovation.

Jolt Capital SAS and Ambrosia Investments Am Sarl (Ambrosia) have announced the acquisition of a 42.94% stake in Alpha MOS SA from Diagnostic Medical Systems (DMS) for €6.47m ($7.22m).

Both Jolt Capital and Ambrosia are private equity firms based in France and Luxembourg respectively.